Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2015

View Archived Issues

has-miR-31 shows promise as a noninvasive biomarker for pharmaco-resistant epilepsy

Innovate UK gives grant to fund Mission Therapeutics' discovery of DUB inhibitors

Microvolume RTH-258 injection effective in treating neovascular age-related macular degeneration

FDA awards grants to boost product development for rare diseases

Q BioMed to acquire Mannin Research assets, including glaucoma candidate

Concert Pharmaceuticals reports phase I results for deuterated ivacaftor CTP-656

Eisai discovers inhibitor of interaction between TRAF6 and TNF superfamily receptors

Zai Lab enters collaboration and license agreement with UCB

Nanoglobular antimicrobial shows in vivo activity against B. cepacea

Purdue Pharma and AnaBios to form joint venture in chronic pain

Fexeric approved in Europe for hyperphosphatemia in patients with chronic kidney disease

Merck & Co. unveils HIV protease inhibitors

Bayer reports new CDK inhibitors

Genentech and Constellation Pharmaceuticals introduce demethylase inhibitors

Sichuan Haisco patents Wnt signaling inhibitors

University of California and McGill University present Mcl-1 inhibitors

Helsinn Healthcare divulges ghrelin receptor antagonists

Glucose-dependent peptide shows promise for diabetes

Esteve strengthens presence in ophthalmology through deal with VSY Biotechnology

CTI BioPharma plans 2015 NDA submission for pacritinib in the treatment of myelofibrosis

VivaGel BV approved in E.U. for bacterial vaginosis

EMA committee recommends European approval of Entresto

Oral treatment for wet AMD shows potential in phase I study, moves to phase II

EMA recommends approval of mepolizumab for severe refractory eosinophilic asthma

MetaStat's MenaCalc assay predicts overall survival in axillary node-negative breast cancer

GSK and Theravance plan Japanese filing for Relvar Ellipta for COPD

EMA CHMP grants accelerated assessment of Janssen's daratumumab for MM

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...